GAINESVILLE, FL--(Marketwire - January 02, 2013) - Quick-Med Technologies, Inc. (OTCQB: [ QMDT ]), a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that it has been awarded a tenth U.S. patent for its novel, non-leaching NIMBUS antimicrobial technology.

The U.S. Patent and Trademark Office has granted Quick-Med Technologies U.S. Patent No. 8,343,523 titled, "Disinfectant with Durable Activity Based on Alcohol-Soluble Quaternary Ammonium Polymers and Copolymers." The new patent provides for a novel alcohol-soluble, water insoluble disinfectant for achieving a prolonged antimicrobial property to a variety of surfaces including skin. It covers the composition and method for several NIMBUS polyurethane quaternary applications including certain formulations of the Company's proprietary NimbuDerma" hand sanitizer and a variety of NIMBUS applications including medical adhesives, foam wound dressings, sutures, catheters and other medical tubing.

"We are very pleased that theU.S. Patent Office has granted this tenth NIMBUS patent which further solidifies our leadership in non-leaching antimicrobial technology," said Bernd Liesenfeld, Quick-Med's president. "This new patent captures additional special characteristics of our unique NIMBUS technology and provides intellectual property protection for several key applications of our growing family of NIMBUS antimicrobial polymers."

About NIMBUS
Quick-Med's patented technology, NIMBUS,is a cutting-edge antimicrobial technology that has been custom designed for wound care and other medical applications. NIMBUSreceived De Novo FDA clearance in 2009 and has been commercialized in traditional wound care applications.It is the only non-leaching antimicrobial dressing which, by design, poses no risk of bacteria developing resistance. NIMBUS technology is protected by twelve U.S. patents and patents pending and 24 foreign counterparts. Additional applications under development include advanced wound dressings, medical adhesives, catheters, and contact lenses.

About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing proprietary, broad-based technologies for infection prevention and control in the consumer and healthcare markets. In addition to NIMBUS, Quick-Med's Stay Fresh technology provides highly durable antimicrobial protection for laundered apparel and other textile applications and its NimbuDerma" technology is being developed as a long-lasting hand sanitizer. For more information, see: [ www.quickmedtech.com ].

2013 Quick-Med Technologies, Inc. All rights reserved. NIMBUS and Stay Fresh are registered trademarks and NimbuDerma" is a trademark of Quick-Med Technologies, Inc.

Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at[ www.sec.gov ].